These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


306 related items for PubMed ID: 17949529

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Management of lower urinary tract symptoms secondary to benign prostatic hyperplasia with open prostatectomy: results of a contemporary series.
    Helfand B, Mouli S, Dedhia R, McVary KT.
    J Urol; 2006 Dec; 176(6 Pt 1):2557-61; discussion 2561. PubMed ID: 17085158
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Preliminary results on selective light vaporization with the side-firing 980 nm diode laser in benign prostatic hyperplasia: an ejaculation sparing technique.
    Leonardi R.
    Prostate Cancer Prostatic Dis; 2009 Dec; 12(3):277-80. PubMed ID: 19322136
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Vaporesection for managing benign prostatic hyperplasia using a 2-microm continuous-wave laser: a prospective trial with 1-year follow-up.
    Fu WJ, Hong BF, Yang Y, Zhang X, Gao JP, Zhang L, Wang XX.
    BJU Int; 2009 Feb; 103(3):352-6. PubMed ID: 18778340
    [Abstract] [Full Text] [Related]

  • 31. High power (80 W) potassium-titanyl-phosphate laser vaporization of the prostate in 66 high risk patients.
    Reich O, Bachmann A, Siebels M, Hofstetter A, Stief CG, Sulser T.
    J Urol; 2005 Jan; 173(1):158-60. PubMed ID: 15592063
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Photoselective vaporization of the prostate: initial experience with a new 80 W KTP laser for the treatment of benign prostatic hyperplasia.
    Hai MA, Malek RS.
    J Endourol; 2003 Mar; 17(2):93-6. PubMed ID: 12689402
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Holmium laser enucleation of the prostate: a size-independent new "gold standard".
    Elzayat EA, Habib EI, Elhilali MM.
    Urology; 2005 Nov; 66(5 Suppl):108-13. PubMed ID: 16194716
    [Abstract] [Full Text] [Related]

  • 37. Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater.
    Kaplan SA, McConnell JD, Roehrborn CG, Meehan AG, Lee MW, Noble WR, Kusek JW, Nyberg LM, Medical Therapy of Prostatic Symptoms (MTOPS) Research Group.
    J Urol; 2006 Jan; 175(1):217-20; discussion 220-1. PubMed ID: 16406915
    [Abstract] [Full Text] [Related]

  • 38. A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia.
    Stovsky MD, Griffiths RI, Duff SB.
    J Urol; 2006 Oct; 176(4 Pt 1):1500-6. PubMed ID: 16952668
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Therapeutic effect of harnal and proscar in treating benign prostatic hyperplasia].
    Tang ZY, Peng KL, Ding J, Zu XB, Qi L.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 30(6):708-10. PubMed ID: 16708816
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 16.